Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05337098 · ClinicalTrials.gov registry record · NA
Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes
A NA study of Insulin Sensitivity and Inflammatory Markers, sponsored by Virginia Polytechnic Institute and State University.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05337098: Recruiting NA study of Insulin Sensitivity and Inflammatory Markers, sponsored by Virginia Polytechnic Institute and State University.
NCT05337098 is a NA study of Insulin Sensitivity and Inflammatory Markers that is actively recruiting participants, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 30 participants, below the 72-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05337098, a NA study of Insulin Sensitivity and Inflammatory Markers, is actively recruiting participants, sponsored by Virginia Polytechnic Institute and State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Animal and observational research in humans suggest that specific types of non-nutritive sweeteners (NNS) may impair glycemic control. However, whether NNS consumption impacts glucose homeostasis in middle-aged/older adults with prediabetes is unknown, and potential mechanisms by which this could occur have yet to be identified. The overall objective of this R21 proposal is to establish proof-of-concept for alterations in glucose homeostasis following intake of sucralose, but not aspartame, in middle-aged/older adults with prediabetes compared to a eucaloric diet with no NNS.
Primary Outcome
The area under the curve (AUC) glucose concentrations, mg/dl from the continuous glucose monitoring at baseline and follow-up will be used
Conditions Studied
Interventions
- OTHER Non-Nutritive Sweetener Intake and impact on glucose homeostasis
Study Locations (1)
Virginia
- Virginia Tech - Blacksburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT05337098 shows while recruiting
NCT05337098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 72-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (58% lower).
The record links to 4 conditions, with Insulin Sensitivity appearing as the primary indexed condition, and to 1 intervention - of which Non-Nutritive Sweetener Intake and impact on glucose homeostasis is the first listed.
NCT05337098 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05337098 about?
NCT05337098 is a clinical study titled "Non-Nutritive Sweetener Consumption and Glucose Homeostasis in Older Adults With Prediabetes". Animal and observational research in humans suggest that specific types of non-nutritive sweeteners (NNS) may impair glycemic control. However, whether NNS consumption impacts glucose homeostasis in middle-aged/older adults with prediabetes is unknown, and potential mechanisms by which this could oc...
What is the current status of trial NCT05337098?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-04-18. Estimated completion is 2026-02-28.
What conditions does trial NCT05337098 study?
This clinical trial studies the following conditions: Insulin Sensitivity, Inflammatory Markers, Continuous Glucose Monitoring, Oral Glucose Tolerance.
What interventions are being tested in trial NCT05337098?
The interventions under investigation include: Non-Nutritive Sweetener Intake and impact on glucose homeostasis (OTHER).
Who is sponsoring clinical trial NCT05337098?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05337098 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05337098's enrollment target sits among peer trials
30 20th of 29 higher than 9 of 29 other Insulin Sensitivity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Sensitivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Effect of Pulsatile Hormone Administration on Insulin Action
RECRUITING · NA
-
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RECRUITING · NA
-
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI